Cite

HARVARD Citation

    Garg, S. et al. (n.d.). 235 Antigen presentation pathways prime melanoma patients for more durable response to anti–PD-1 checkpoint blockade therapy. Journal for immunotherapy of cancer. p. A252. [Online]. 
  
Back to record